Open position for a doctoral candidate in a collaborative project between Prof. Klaus Elenius’ lab and Dr. Kari J. Kurppa’s lab
The Cancer Biology laboratories of Klaus Elenius and Kari Kurppa are looking for a doctoral candidate to join a collaborative project. The two laboratories, led by the principal investigators Professor Klaus Elenius, MD/PhD and Dr. Kari J. Kurppa, PhD, aim to develop novel means to specifically target cancer cell signaling and drug resistance. Click here for further details of the position and how to apply.
Please note that the deadline for applications is May 3, 2021 (11:59 PM UTC+3). Preferable starting date is May 17, 2021, but due to the COVID-19 situation, the starting date is negotiable. For any inquiries, please contact Klaus Elenius, klaus.elenius[at]utu.fi or Kari Kurppa, kjkurp[at]utu.fi.
Turkulaiset syöpätutkijat professori Johanna Ivaska ja professori Jukka Westermarck kertoivat suositun Tanssii Tähtien Kanssa ohjelman Roosa nauha -lähetyksessä syöpätutkimuksen rahoituksen tärkeydestä ja tämänhetkisestä tilanteesta Suomessa. Jakson voit katsoa ilmaiseksi MTV katsomosta – Ivaskan ja Westermarckin puheenvuorot kohdasta 36:06-39:40. Hyväntekeväisyyslähetyksen aikana saatiin yli 10 000 uutta kuukausilahjoittajaa ja yli puoli miljoonaa kertalahjoitusta Syöpäsäätiön Roosa nauha -kampanjaan.
Two open positions for doctoral candidates in Dr. Kari J. Kurppa’s lab
The Cancer Drug Resistance laboratory (www.utu.fi/kurppalab) is looking for two doctoral candidates to join a new and exciting research group in the University of Turku, Turku, Finland. Click here for further details of the position and how to apply.
Please note that the deadline for applications is on June 30th, 2020.
Open position for a PhD in Prof. Jukka Westermarck’s lab
Position for a PhD (or soon-to-be) is available in the laboratory of Professor Jukka Westermarck at Turku Bioscience, University of Turku, Turku, Finland. We are looking for a highly motivated researcher with a PhD degree to join our dynamic research group broadly focused on very exciting therapeutic potential of phosphatases for cancer therapy (https://bioscience.fi/research/cancer-cell-signaling/profile/). Click here for further details of the position and how to apply.
Please note that the deadline for applications is on 31st of May 2020.
“Cancerforskare i Åbo samarbetar för ännu bättre resultat”
Svenska YLE has made an article and a radio interview about 30-year-old Turku Cancer Research Society. You can find the article and the recordings in here!
Turku Cancer Research Society hosted a day-long seminar with a focus on cancer drug development in an academic setting. The seminar brought together international experts with different aspects on cancer drug development from small-molecule development to clinical trials, and over 200 attendees including academic researchers and scientists from local industries.
A key focus of the seminar was the major challenge of translating the findings of basic research into drug development and innovative medicines that would benefit cancer patients. To overcome this challenge, specific drug development centers providing industry-standard small-molecule development have been founded within academic institutions for example in Belgium and in the U.K.
The seminar also provided exciting views on the recent developments in the discovery of small molecules targeting the ‘undruggable’ cancer targets.
News about the seminar (in Finnish):
Video: Prof. Jukka Westermarck on ‘undruggable’ cancer drug targets
Mediuutiset news article on the seminar
“Lääkekehityskeskus pelastaisi lääkeaihiot”
The media release of the University of Turku
“Akateemisesta perustutkimuksesta tuottavaan lääkekehitykseen – kansainvälisessä seminaarissa pohditaan, miten syöpälääketutkimuksessa menestytään”
